327 related articles for article (PubMed ID: 31354735)
1. History of Envenoming Therapy and Current Perspectives.
Pucca MB; Cerni FA; Janke R; Bermúdez-Méndez E; Ledsgaard L; Barbosa JE; Laustsen AH
Front Immunol; 2019; 10():1598. PubMed ID: 31354735
[TBL] [Abstract][Full Text] [Related]
2. Immunological profile of antivenoms: preclinical analysis of the efficacy of a polyspecific antivenom through antivenomics and neutralization assays.
Gutiérrez JM; Lomonte B; Sanz L; Calvete JJ; Pla D
J Proteomics; 2014 Jun; 105():340-50. PubMed ID: 24583507
[TBL] [Abstract][Full Text] [Related]
3. Biosynthetic Oligoclonal Antivenom (BOA) for Snakebite and Next-Generation Treatments for Snakebite Victims.
Kini RM; Sidhu SS; Laustsen AH
Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30551565
[TBL] [Abstract][Full Text] [Related]
4. Current research into snake antivenoms, their mechanisms of action and applications.
Silva A; Isbister GK
Biochem Soc Trans; 2020 Apr; 48(2):537-546. PubMed ID: 32196542
[TBL] [Abstract][Full Text] [Related]
5. Innovative Immunization Strategies for Antivenom Development.
Bermúdez-Méndez E; Fuglsang-Madsen A; Føns S; Lomonte B; Gutiérrez JM; Laustsen AH
Toxins (Basel); 2018 Nov; 10(11):. PubMed ID: 30400220
[TBL] [Abstract][Full Text] [Related]
6. A Review of the Proteomic Profiling of African Viperidae and Elapidae Snake Venoms and Their Antivenom Neutralisation.
Offor BC; Muller B; Piater LA
Toxins (Basel); 2022 Oct; 14(11):. PubMed ID: 36355973
[TBL] [Abstract][Full Text] [Related]
7. Prototyping of a lateral flow assay based on monoclonal antibodies for detection of Bothrops venoms.
Knudsen C; Jürgensen JA; D Knudsen P; Oganesyan I; Harrison JA; Dam SH; Haack AM; Friis RUW; Vitved L; Belfakir SB; Ross GMS; Zenobi R; H Laustsen A
Anal Chim Acta; 2023 Sep; 1272():341306. PubMed ID: 37355315
[TBL] [Abstract][Full Text] [Related]
8. Defining the pathogenic threat of envenoming by South African shield-nosed and coral snakes (genus Aspidelaps), and revealing the likely efficacy of available antivenom.
Whiteley G; Casewell NR; Pla D; Quesada-Bernat S; Logan RAE; Bolton FMS; Wagstaff SC; Gutiérrez JM; Calvete JJ; Harrison RA
J Proteomics; 2019 Apr; 198():186-198. PubMed ID: 30290233
[TBL] [Abstract][Full Text] [Related]
9. The medical threat of mamba envenoming in sub-Saharan Africa revealed by genus-wide analysis of venom composition, toxicity and antivenomics profiling of available antivenoms.
Ainsworth S; Petras D; Engmark M; Süssmuth RD; Whiteley G; Albulescu LO; Kazandjian TD; Wagstaff SC; Rowley P; Wüster W; Dorrestein PC; Arias AS; Gutiérrez JM; Harrison RA; Casewell NR; Calvete JJ
J Proteomics; 2018 Feb; 172():173-189. PubMed ID: 28843532
[TBL] [Abstract][Full Text] [Related]
10. Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa.
Williams DJ; Gutiérrez JM; Calvete JJ; Wüster W; Ratanabanangkoon K; Paiva O; Brown NI; Casewell NR; Harrison RA; Rowley PD; O'Shea M; Jensen SD; Winkel KD; Warrell DA
J Proteomics; 2011 Aug; 74(9):1735-67. PubMed ID: 21640209
[TBL] [Abstract][Full Text] [Related]
11. Antivenomics and in vivo preclinical efficacy of six Latin American antivenoms towards south-western Colombian Bothrops asper lineage venoms.
Mora-Obando D; Pla D; Lomonte B; Guerrero-Vargas JA; Ayerbe S; Calvete JJ
PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009073. PubMed ID: 33524033
[TBL] [Abstract][Full Text] [Related]
12. Antivenoms for the treatment of snakebite envenomings: the road ahead.
Gutiérrez JM; León G; Burnouf T
Biologicals; 2011 May; 39(3):129-42. PubMed ID: 21429763
[TBL] [Abstract][Full Text] [Related]
13. Recombinant snake antivenoms get closer to the clinic.
Laustsen AH
Trends Immunol; 2024 Apr; 45(4):225-227. PubMed ID: 38538486
[TBL] [Abstract][Full Text] [Related]
14. From Fangs to Pharmacology: The Future of Snakebite Envenoming Therapy.
Laustsen AH; Engmark M; Milbo C; Johannesen J; Lomonte B; Gutiérrez JM; Lohse B
Curr Pharm Des; 2016; 22(34):5270-5293. PubMed ID: 27339430
[TBL] [Abstract][Full Text] [Related]
15. Envenoming and antivenom use in Australia.
White J
Toxicon; 1998 Nov; 36(11):1483-92. PubMed ID: 9792162
[TBL] [Abstract][Full Text] [Related]
16. Bee Updated: Current Knowledge on Bee Venom and Bee Envenoming Therapy.
Pucca MB; Cerni FA; Oliveira IS; Jenkins TP; Argemí L; Sørensen CV; Ahmadi S; Barbosa JE; Laustsen AH
Front Immunol; 2019; 10():2090. PubMed ID: 31552038
[TBL] [Abstract][Full Text] [Related]
17. Clinical effects and treatment of envenoming by Hoplocephalus spp. snakes in Australia: Australian Snakebite Project (ASP-12).
Isbister GK; White J; Currie BJ; O'Leary MA; Brown SG;
Toxicon; 2011 Dec; 58(8):634-40. PubMed ID: 21967812
[TBL] [Abstract][Full Text] [Related]
18. Antibody Cross-Reactivity in Antivenom Research.
Ledsgaard L; Jenkins TP; Davidsen K; Krause KE; Martos-Esteban A; Engmark M; Rørdam Andersen M; Lund O; Laustsen AH
Toxins (Basel); 2018 Sep; 10(10):. PubMed ID: 30261694
[TBL] [Abstract][Full Text] [Related]
19. Antivenoms for snakebite envenomings.
Gutiérrez JM; León G; Lomonte B; Angulo Y
Inflamm Allergy Drug Targets; 2011 Oct; 10(5):369-80. PubMed ID: 21745181
[TBL] [Abstract][Full Text] [Related]
20. Revolutionizing snakebite care with novel antivenoms: Breakthroughs and barriers.
Uko SO; Malami I; Ibrahim KG; Lawal N; Bello MB; Abubakar MB; Imam MU
Heliyon; 2024 Feb; 10(3):e25531. PubMed ID: 38333815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
